Upstream Bio, Inc. (UPB)
1.59
-0.41
(-20.50%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.03
(+1.89%)
After-Hours: 20:00
Upstream Bio Price : 1.59 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 1.98 | 2.06 | 1.56 | 1.59 | 1.388M |
| Nov 19, 2026 | 2.09 | 2.19 | 2.00 | 2.00 | 856121.0 |
| Nov 18, 2026 | 2.16 | 2.19 | 2.05 | 2.08 | 1.239M |
| Nov 17, 2026 | 2.10 | 2.205 | 2.005 | 2.10 | 1.183M |
| Nov 16, 2026 | 2.82 | 2.83 | 2.12 | 2.15 | 1.994M |
| Nov 13, 2026 | 2.86 | 2.98 | 2.73 | 2.78 | 891335.0 |
| Nov 12, 2026 | 3.13 | 3.13 | 2.80 | 2.86 | 2.529M |
| Nov 11, 2026 | 3.38 | 3.46 | 3.13 | 3.20 | 1.319M |
| Nov 10, 2026 | 3.52 | 3.655 | 3.24 | 3.38 | 1.175M |
| Nov 09, 2026 | 3.23 | 3.595 | 3.17 | 3.58 | 1.984M |
| Nov 06, 2026 | 3.24 | 3.28 | 3.02 | 3.23 | 1.140M |
| Nov 05, 2026 | 3.64 | 3.675 | 3.00 | 3.21 | 1.066M |
| Nov 04, 2026 | 3.59 | 3.842 | 3.520 | 3.70 | 1.247M |
| Nov 03, 2026 | 3.36 | 3.525 | 3.305 | 3.39 | 978510.0 |
| Nov 02, 2026 | 3.42 | 3.46 | 3.16 | 3.35 | 936309.0 |
| Oct 30, 2026 | 3.26 | 3.425 | 3.15 | 3.41 | 946124.0 |
| Oct 29, 2026 | 3.00 | 3.32 | 2.97 | 3.27 | 1.179M |
| Oct 28, 2026 | 2.78 | 2.99 | 2.68 | 2.98 | 1.323M |
| Oct 27, 2026 | 2.76 | 2.935 | 2.68 | 2.79 | 1.180M |
| Oct 26, 2026 | 2.75 | 2.97 | 2.72 | 2.75 | 983845.0 |
| Oct 23, 2026 | 2.95 | 2.96 | 2.695 | 2.74 | 1.051M |
| Oct 22, 2026 | 2.77 | 2.99 | 2.70 | 2.99 | 1.450M |
| Oct 21, 2026 | 2.83 | 2.975 | 2.765 | 2.80 | 1.410M |
| Oct 20, 2026 | 2.79 | 3.09 | 2.78 | 2.82 | 1.676M |
| Oct 19, 2026 | 2.76 | 3.07 | 2.75 | 2.80 | 1.604M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
| Arrowhead Pharmaceuticals, Inc. | 41.37 |
Price Related Metrics
| PS Ratio | 30.18 |
| PEG Ratio | -0.0166 |
| Price to Book Value | 0.3725 |
| Earnings Yield | -189.5% |
| Market Cap | 87.15M |
| PEGY Ratio | -0.0166 |